PRKCA and pancreatic neoplasm: Inhibition of PKCι alone [249] or in combination with other inhibitors (e.g., specificity protein 1 (Sp1) inhibitor) [250] reduced cell growth and metastasis and induced apoptosis in pancreatic cancer cells.